Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

In-Line Diagnostics Corp. — Predicate Candidate Screening

8 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

191 daysmedian FDA review time
419 days90th percentile
8clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K001763CRIT-LINE MONITOR III (CLM III)In-Line Diagnostics Corp.2000-12-201910
K992227CRIT-LINE MONITOR III (CLM III)In-Line Diagnostics Corp.1999-07-30280
K983551CRIT-SCAN II MONITORIn-Line Diagnostics Corp.1999-05-272300
K982412MODIFICATION OF CRIT-LINE MONITOR III (CLM III)In-Line Diagnostics Corp.1998-10-09880
K972470CRIT-LINE MONITOR (CLMIII)In-Line Diagnostics Corp.1997-12-111630
K953875CRIT-LINE HEMATOCRIT ALERT (MODIFICATION)In-Line Diagnostics Corp.1996-07-233910
K950942CRIT-LINE HEMATOCRIT ALERTIn-Line Diagnostics Corp.1995-03-14270
K935958CRIT-LINE BLOOD CHAMBER WITH E-BEAMIn-Line Diagnostics Corp.1995-01-194191

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda